Related Experiment Video
Updated: Jul 21, 2025

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
A Review on Enterocin DD14, the Leaderless Two-Peptide Bacteriocin with Multiple Biological Functions and Unusual
Rabia Ladjouzi1, Elodie Dussert1, Radja Teiar1
1UMR Transfrontalière BioEcoAgro, INRAe 1158, ICV-Institut Charles Viollette, University Lille, INRAE, University Liège, UPJV, YNCREA, University Artois, University Littoral Côte d'Opale, F-59000 Lille, France.
Abstract:
Enterocin DD14 (EntDD14) is a two-peptide leaderless bacteriocin (LLB) produced by Enterococcus faecalis 14, a human strain isolated from meconium. Studies performed on EntDD14 enabled it to show its activity against Gram-positive bacteria such as Listeria monocytogenes, Clostridium perfringens, Enterococcus faecalis, and Staphylococcus aureus. EntDD14 was also shown to potentiate the activity of different antibiotics such as erythromycin, kanamycin, and methicillin when assessed against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo in the NMRI-F holoxenic mouse model. Additionally, EntDD14 has an antiviral activity and decreased the secretion of pro-inflammatory IL-6 and IL-8 in inflamed human intestinal Caco-2 cells. The genome of E. faecalis 14 was sequenced and annotated. Molecular tools such as Bagel4 software enabled us to locate a 6.7kb-EntDD14 cluster. Transport of EntDD14 outside of the cytoplasm was shown to be performed synergistically by a channel composed of two pleckstrin-homology-domain-containing proteins, namely DdE/DdF and the ABC transporter DdGHIJ. This latter could also protect the bacteriocinogenic strain against extracellular EntDD14. Here, we focus on academic data and potential therapeutic issues of EntDD14, as a model of two-peptide LLB.
Insights
Enterocin DD14, a bacteriocin from human Enterococcus faecalis, shows broad-spectrum antimicrobial and antiviral activities. It also enhances antibiotic efficacy against MRSA and reduces inflammation, suggesting therapeutic potential.
Area of Science:
- Microbiology
- Bacteriocin Research
- Therapeutic Agent Development
Background:
- Enterocin DD14 (EntDD14) is a novel two-peptide leaderless bacteriocin (LLB) produced by the human commensal strain *Enterococcus faecalis* 14.
- Bacteriocins are ribosomally synthesized antimicrobial peptides with potential applications in medicine and biotechnology.
Purpose of the Study:
- To characterize the antimicrobial, antiviral, and immunomodulatory properties of EntDD14.
- To investigate the genetic basis and transport mechanism of EntDD14 production.
- To explore the therapeutic potential of EntDD14, particularly in combination with antibiotics.
Main Methods:
- Antimicrobial and antiviral activity assays against various Gram-positive pathogens and cell lines.
- Genome sequencing and annotation of *E. faecalis* 14 using bioinformatics tools like Bagel4.
- In vitro and in vivo studies using a mouse model to assess EntDD14's potentiation of antibiotic activity against MRSA.
- Analysis of pro-inflammatory cytokine secretion in human intestinal cells.
Main Results:
- EntDD14 demonstrated potent activity against *Listeria monocytogenes*, *Clostridium perfringens*, *Enterococcus faecalis*, and *Staphylococcus aureus*.
- EntDD14 significantly potentiated the efficacy of erythromycin, kanamycin, and methicillin against MRSA in vitro and in vivo.
- EntDD14 exhibited antiviral properties and reduced the secretion of pro-inflammatory IL-6 and IL-8 in Caco-2 cells.
- The EntDD14 cluster was identified, and its transport was shown to involve a complex system of PH-domain proteins (DdE/DdF) and an ABC transporter (DdGHIJ).
Conclusions:
- EntDD14 is a promising multifunctional bacteriocin with significant antimicrobial, antiviral, and immunomodulatory effects.
- The unique transport mechanism highlights novel strategies for bacteriocin export and self-protection.
- EntDD14 represents a valuable model for studying two-peptide LLBs and holds potential for therapeutic applications, including combating antibiotic-resistant bacteria.
More Related Videos
Related Concept Videos
Biological Methods for Microbial Control
Gram-negative Bacterial Protein Secretion Systems
Bacterial Translocation and Protein Secretion

